SCHEMBL9904533

SCHEMBL9904533

Cn1c(Cc2cnc(SCc3ccc(Oc4ccc(Cl)c(C(F)(F)F)c4)cc3)[nH]c2=O)cc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 17/20 0.49
DAO P14920 1/20 0.38
NR1H2 P55055 2/20 0.37
NR1H3 Q13133 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9107684 0.85 PLA2G7 (0.39) PLA2G7NR1H2NR1H3
SCHEMBL9900452 0.80 PLA2G7 (0.55) PLA2G7DAO
SCHEMBL9904535 0.79 PLA2G7 (0.39) PLA2G7NR1H2NR1H3
SCHEMBL9889604 0.74 MCL1 (0.35) PLA2G7
SCHEMBL9900826 0.74 CA12 (0.49) PLA2G7DAO
SCHEMBL9108610 0.72 PLA2G7 (0.37) PLA2G7
SCHEMBL9901961 0.72 PLA2G7 (0.57) PLA2G7
SCHEMBL9900816 0.72 PLA2G7 (0.47) PLA2G7
SCHEMBL9900408 0.71 PLA2G7 (0.56) PLA2G7
SCHEMBL9104868 0.71 FLT1 (0.38) PLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649053-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 Glaxo Group Limited (GB) 2013-10-16 EP disclosed
WO-2012076435-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 GLAXO GROUP LIMITED (GB) 2012-06-14 WO disclosed